Notes Payable (Details Narrative) - USD ($)
|
|
|
|
|
3 Months Ended |
9 Months Ended |
|
|
|
Aug. 23, 2017 |
May 15, 2017 |
Feb. 14, 2017 |
Feb. 10, 2017 |
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
Aug. 29, 2017 |
Dec. 31, 2016 |
Nov. 14, 2016 |
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Aggregate additional advances received |
|
|
|
|
|
|
$ 257,645
|
$ 600,000
|
|
|
|
| Repayment of advances received |
|
|
|
|
|
|
4,815
|
135,428
|
|
|
|
| Derivative liability |
|
|
|
|
$ 26,628,006
|
|
26,628,006
|
|
|
$ 1,583,103
|
|
| Accrued purchase obligation |
|
|
|
|
1,224,048
|
|
1,224,048
|
|
|
|
|
| Debt discount |
|
|
|
|
41,622
|
|
41,622
|
|
|
$ 0
|
|
| Receiving amount from equity or through debt financings |
|
|
|
|
|
|
949,900
|
|
|
|
|
| Proceeds from public offering |
|
|
|
|
|
|
20,000,000
|
|
|
|
|
| Interest expense, net |
|
|
|
|
95,215
|
$ 57,937
|
445,510
|
$ 128,489
|
|
|
|
| Executive Chairman [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument maturity date |
|
|
May 15, 2017
|
May 09, 2017
|
|
|
|
|
|
|
|
| Principal amount |
|
|
$ 25,000
|
$ 22,567
|
$ 50,000
|
|
$ 50,000
|
|
|
|
$ 410,000
|
| Number of warrant to purchase of common stock shares |
|
|
|
|
|
|
|
|
3,100,000
|
|
|
| Debt instrument interest rate |
|
|
10.00%
|
10.00%
|
15.00%
|
|
15.00%
|
|
|
|
|
| Debt conversion price per share |
|
|
|
|
$ 35.00
|
|
$ 35.00
|
|
|
|
|
| Proceeds from public offering |
|
|
$ 10,000,000
|
$ 10,000,000
|
|
|
|
|
|
|
|
| Notes Payable [Member] | Lenders [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument maturity date |
|
|
|
|
|
|
Dec. 29, 2017
|
|
|
|
|
| Principal amount |
|
|
|
|
$ 260,000
|
|
$ 260,000
|
|
|
|
|
| Number of warrant to purchase of common stock shares |
|
|
|
|
15,600
|
|
15,600
|
|
|
|
|
| Warrant term |
|
|
|
|
|
|
5 years
|
|
|
|
|
| Fair value of warrants |
|
|
|
|
|
|
$ 52,260
|
|
|
|
|
| Debt instrument interest rate |
|
|
|
|
12.00%
|
|
12.00%
|
|
|
|
|
| Receiving amount from equity or through debt financings |
|
|
|
|
|
|
$ 5,000,000
|
|
|
|
|
| Warrant exercise price |
|
|
|
|
$ 35.00
|
|
$ 35.00
|
|
|
|
|
| Warrant description |
|
|
|
|
|
|
The issuances of these notes, the Company issued five-year warrants to purchase an aggregate of 15,600 shares of common stock at an exercise price the lower of $35.00 per share or a price equal to a twenty percent discount to the price per share sold in any equity financing transaction within the next twelve months whereby the Company cumulatively receives at least $1,000,000.
|
|
|
|
|
| Notes Payable One [Member] | Lenders [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument maturity date |
|
|
|
|
|
|
Dec. 29, 2017
|
|
|
|
|
| Principal amount |
|
|
|
|
$ 50,000
|
|
$ 50,000
|
|
|
|
|
| Number of warrant to purchase of common stock shares |
|
|
|
|
10,000
|
|
10,000
|
|
|
|
|
| Warrant term |
|
|
|
|
|
|
5 years
|
|
|
|
|
| Inducement expense |
|
|
|
|
|
|
$ 33,500
|
|
|
|
|
| Receiving amount from equity or through debt financings |
|
|
|
|
|
|
$ 5,000,000
|
|
|
|
|
| Warrant exercise price |
|
|
|
|
$ 35.00
|
|
$ 35.00
|
|
|
|
|
| Warrant description |
|
|
|
|
|
|
The extension the Company issued the lender a five-year warrant to purchase 10,000 shares of common stock with an exercise price the lower of $35.00 per share or a price equal to a twenty percent (20%) discount to the price per share sold in any equity financing transaction within the next twelve months whereby the Company cumulatively receives at least $1,000,000.
|
|
|
|
|
| Convertible Notes Payable One [Member] | Executive Chairman [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
$ 545,000
|
|
$ 545,000
|
|
|
|
|
| Promissory Notes [Member] | Executive Chairman [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
$ 160,078
|
|
$ 160,078
|
|
|
|
|
| Debt instrument interest rate |
|
|
|
|
10.00%
|
|
10.00%
|
|
|
|
|
| Proceeds from public offering |
|
|
|
|
|
|
$ 2,500,000
|
|
|
|
|
| Securities and Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument maturity date |
|
Dec. 15, 2017
|
|
|
|
|
|
|
|
|
|
| Accrued default penalty |
|
|
|
|
$ 12,000,000
|
|
$ 12,000,000
|
|
|
|
|
| Non-assessable origination shares percentage |
|
48.00%
|
|
|
|
|
|
|
|
|
|
| Warrant to purchase of common stock description |
|
(i) $35.00 per share, or (ii) the lowest daily closing price of the Common Stock during the ten days prior to delivery of the Origination Shares (subject to adjustment for stock splits), or (iii) 80% of the Common Stock offering price of the public offering, or (iv) 80% of the unit price offering price of the public offering (if applicable), or (v) the exercise price of any warrants issued in the public offering.
|
|
|
|
|
|
|
|
|
|
| Number of shares of common stock outstanding percentage |
|
9.99%
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
$ 99,649
|
|
|
|
|
|
|
|
|
|
| Number of warrant to purchase of common stock shares |
|
|
|
|
44,289
|
|
44,289
|
|
|
|
|
| Warrant term |
|
|
|
|
|
|
5 years
|
|
|
|
|
| Derivative liability |
|
|
|
|
$ 80,056
|
|
$ 80,056
|
|
|
|
|
| Aggregate exercise price of warrants |
|
|
|
|
|
|
1,550,110
|
|
|
|
|
| Accrued purchase obligation |
|
|
|
|
1,224,048
|
|
1,224,048
|
|
|
|
|
| Placement agent fees and other issuance costs |
|
|
|
|
|
|
1,594,139
|
|
|
|
|
| Debt discount |
|
|
|
|
54,322
|
|
54,322
|
|
|
|
|
| Debt discount recognized over the term value |
|
|
|
|
$ 1,539,817
|
|
1,539,817
|
|
|
|
|
| Securities and Purchase Agreement [Member] | JMJ [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Aggregate additional advances received |
|
|
|
|
|
|
2,550,100
|
|
|
|
|
| Repayment of advances received |
|
|
|
|
|
|
1,649,749
|
|
|
|
|
| Securities and Purchase Agreement [Member] | Promissory Note [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Aggregate additional advances received |
|
|
|
|
|
|
$ 1,550,100
|
|
|
|
|
| BLNK Conversion Agreement [Member] | Executive Chairman [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Debt conversion of convertible into shares |
209,442
|
|
|
|
|
|
|
|
|
|
|
| Debt conversion percentage |
80.00%
|
|
|
|
|
|
|
|
|
|
|